Navigation Links
Cardea Bio and Nanosens Innovations Inc. Merger-Acquisition Finalized
Date:10/10/2019

Cardea is excited to announce the finalization of their merger-acquisition of Nanosens Innovations, Inc., the creators of CRISPR-Chip™. Cardea first broke the news of the proposed merger in September, along with the announcement of their Early Access Program for the Genome Sensor™. Built with CRISPR-Chip technology, the Genome Sensor is the world’s first DNA search engine. It can google genomes to detect genetic mutations and variations.

Merging the two companies allows the power of Nanosens’ CRISPR-Chip technology to be combined with Cardea’s graphene biosensor infrastructure. This enables Cardea to build an advanced DNA version of its “biology-based transistors” which would otherwise normally work with proteins. Via the “Powered by Cardea” strategy, a series of new CRISPR-Chip DNA-focused products will be developed and marketed via Cardea’s partnerships with large companies in different markets.

“We are thrilled to announce that both companies’ Board of Directors and Shareholders have strongly supported the merger by voting yes to combining the two companies. I’d like to thank everyone who has made this possible. We here at Cardea are excited to expand our team?of talents with the talents from?Nanosens,”?says Cardea’s CEO, Michael?Heltzen.?

Nanosens will continue as a Cardea brand for the Genome Sensor and other tools made for the research market. They are currently accepting applications to the Genome Sensor Early Access Program where a select few will have exclusive access to the Genome Sensor before the rest of the world.

“With?Nanosens?as our internal Innovation Partner,?and?a handful of external Innovation Partnerships soon to be signed, we are ready to take in the investments we have been offered and scale up Cardea. This will take us to the next level on our venture to build the biology-based transistor?company that allows for people to connect computers directly with biology,”?continues?Heltzen.?

Cardea is actively looking for companies to partner with and co-develop new products through their Innovation Partnership Program. Partners will be able to utilize the unique features of Cardea’s “biology-based transistors” for future products. These features include near real-time detection, outside-the-lab DNA detection, and handheld user-friendly devices that enable insight to the biology systems in and around us. For more info, please visit http://www.cardeabio.com

Read the full story at https://www.prweb.com/releases/cardea_bio_and_nanosens_innovations_inc_merger_acquisition_finalized/prweb16635046.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Cardea Bio and Nanosens Innovations Look to Combine Companies
2. Nanosensors could aid drug manufacturing
3. Biologists develop nanosensors to visualize movements and distribution of plant hormone
4. Mount Sinai celebrates team science at second-annual SINAInnovations Conference Nov. 18-19, 2013
5. Ben-Gurion U. and UChicago research collaboration targets water resource innovations
6. Innovations save lives of mothers and children
7. 83 global health innovations receive Grand Challenges Canada funding
8. NREL expert honored for energy systems innovations
9. NREL staff recognized for top innovations
10. NIH and NSF collaborate to accelerate biomedical research innovations into the marketplace
11. NSF and NIH collaborate to accelerate advance of biomedical innovations into the marketplace
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/28/2020)... ... January 28, 2020 , ... ... and government agencies, announced that the firm has established a presence in Cambridge, ... office will be in the Cambridge Innovation Center (CIC), at One Broadway in ...
(Date:1/27/2020)... ... January 27, 2020 , ... On Thursday, February 20, 2020 at ... Reed Tech and Richard Castle, Global Account Manager Medical Device at ... other topics include EU MDR timing deadlines, best practices in creating and submitting product ...
(Date:1/24/2020)... ... January 24, 2020 , ... Shoreline Biome , a microbiome ... today announced that the company will debut a novel new DNA isolation kit at ... new product, Shoreline Biome's Rapid Prep kit, is a fast and easy-to-use kit designed ...
Breaking Biology News(10 mins):
(Date:1/27/2020)... ... January 27, 2020 , ... Valencell, the leading innovator in ... led by Halma plc , a FTSE 100 global group of life-saving ... and WSJ Joshua Fund. A representative from Halma will join the Valencell board ...
(Date:1/24/2020)... ... January 24, 2020 , ... Sierra Instruments, global leader ... and controllers ideal for BioPharm OEMS. Sierra also announces RedyCompact™ ... thermal instruments employ high-precision MEMS (Micro-Electro Mechanical Systems) technology utilizing an advanced, ultra-stable ...
(Date:1/22/2020)... ... 2020 , ... Microbial Discovery Group LLC (MDG) is pleased ... Institutional (I&I) Account Manager. Darrell will focus on servicing MDG’s partners with strategic ... years of sales experience working across multiple different market sectors such as; transportation, ...
(Date:1/10/2020)... ... January 09, 2020 , ... A new report from ... vendor qualification process, a critical element of clinical trial set up and execution. ... vendor qualification process creates delays in initiation in 7% of clinical trials for ...
Breaking Biology Technology: